Jing Cheng

Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA

CapitalBio Corp. develops and commercializes biochip products. It offers biochip-related products for genomic, proteomic and cellomic research, bio-safety testing, clinical applications and to address wider human health needs. The company is headquartered in Beijing, China.

AVIVA Biosciences Corp. develops instrument platforms, consumables and biological assay systems. It leverages biochip micro technologies and has develops applications to serve unmet needs of the healthcare and life science industries. The company was founded by Julian Yuan and Jing Ching in 1999 and is headquartered in San Diego, CA.